2 ms·
We're talking about a drug that's going on 50 years on the market, not a startup. The drug has already been monetized and paid for itself 100x times over.
by cptskippy 7y ago
We're talking about a drug that's going on 50 years on the market, not a startup. The drug has already been monetized and paid for itself 100x times over.
- manigandham 7y agoNothing wrong with going until 200x. Cost != affordability. It's a misdirection of the real issues with the medical industry.